Along the same lines, KMT2D would, if being a genuine tumor predisposition gene (TPG), predispose to a rather wide range of malignancies including bone- and soft-tissue tumors, hematological malignancies, embryonal tumors and carcinoma’s. This evidence concerns the gene KMT2D and embryonal neoplasm.